Brain tissue oxygen and outcome after severe traumatic brain injury: A systematic review*
Authors:
- Vicente GraciasVGVicente Gracias
- Arthur ItkinAIArthur Itkin
- Katherine HoffmanKHKatherine Hoffman
- Stephanie BloomSBStephanie Bloom
- Wei YangWYWei Yang
- Susan ChristianSCSusan Christian
- Peter D. LeRouxPLPeter D. LeRoux
- 1 June 2009
- journal article
- review article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 37 (6) , 2057-2063
Abstract
In this study, available medical literature were reviewed to determine whether brain hypoxia as measured by brain tissue oxygen (Bto2) levels is associated with increased risk of poor outcome after traumatic brain injury (TBI). A secondary objective was to examine the safety profile of a direct BtO2 probe. Clinical studies published between 1993 and 2008 were identified from electronic databases, Index Medicus, bibliographies of pertinent articles, and expert consultation. The following inclusion criteria were applied for outcome analysis: 1) more than 10 patients described, 2) use of a direct Bto2 monitor, 3) brain hypoxia defined as Bto2 15 or 30 minutes, 4) 6-month outcome data, and 5) clear reporting of patient outcome associated with Bto2. For the analysis, each selected article had to have adequate data to determine odds ratios (ORs) and confidence intervals (CIs). Thirteen studies met the initial inclusion criteria and three were included in the final outcome analysis. Safety data were abstracted from any report where it was mentioned. The three studies included 150 evaluable patients with severe TBI (Glasgow Coma Scale ≤8). Brain hypoxia was identified in 71 (47%) of these patients. Among the patients with brain hypoxia, 52 (73%) had unfavorable outcome including 39 (55%) who died. In the absence of brain hypoxia, 34 (43%) patients had an unfavorable outcome, including 17 (22%) who died. Overall brain hypoxia (Bto2 15 minutes) was associated with worse outcome (OR 4.0; 95% CI 1.9–8.2) and increased mortality (OR 4.6; 95% CI 2.2–9.6). We reviewed published safety data; in 292 patients monitored with a Bto2 probe, only two adverse events were reported. Summary results indicate that brain hypoxia (<10 mm Hg) is associated with worse outcome after severe TBI and that Bto2 probes are safe. These results imply that treating patients to increase Bto2 may improve outcome after severe TBI. This question will require further study.Keywords
This publication has 55 references indexed in Scilit:
- Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trialThe Lancet Neurology, 2006
- Clinical Trials in Head InjuryJournal of Neurotrauma, 2002
- Future of neuroprotective drugs in doubtNature Medicine, 2002
- Lack of Effect of Induction of Hypothermia after Acute Brain InjuryNew England Journal of Medicine, 2001
- Prevention of secondary ischemic insults after severe head injuryCritical Care Medicine, 1999
- Current Status of Neuroprotection Trials for Traumatic Brain Injury: Lessons from Animal Models and Clinical StudiesNeurosurgery, 1999
- The European Brain Injury Consortium Survey of Head InjuriesActa Neurochirurgica, 1999
- THE ROLE OF SECONDARY BRAIN INJURY IN DETERMINING OUTCOME FROM SEVERE HEAD INJURY1993
- Selective Loss of Neurons From the Thalamic Reticular Nucleus Following Severe Human Head InjuryJournal of Neurotrauma, 1993
- Ischaemic brain damage is still common in fatal non-missile head injury.Journal of Neurology, Neurosurgery & Psychiatry, 1989